Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q28185790)
Watch
English
The role of antileukotrienes in the treatment of asthma
scientific article (publication date: June 2001)
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
11426914
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11426914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
review article
1 reference
stated in
Europe PubMed Central
title
The role of antileukotrienes in the treatment of asthma
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11426914
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11426914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
main subject
asthma
0 references
author name string
P E Korenblat
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11426914
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11426914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
Antileukotriene Working Group
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
11426914
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11426914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
language of work or name
English
0 references
publication date
1 June 2001
1 reference
stated in
Europe PubMed Central
PubMed ID
11426914
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11426914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
published in
Annals of Allergy, Asthma & Immunology
1 reference
stated in
Europe PubMed Central
PubMed ID
11426914
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11426914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
volume
86
1 reference
stated in
Europe PubMed Central
PubMed ID
11426914
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11426914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
issue
6 Suppl 1
1 reference
stated in
Europe PubMed Central
PubMed ID
11426914
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11426914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
page(s)
31-39
1 reference
stated in
Europe PubMed Central
PubMed ID
11426914
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11426914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
cites work
Cellular events in the bronchi in mild asthma and after bronchial provocation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management of asthma with zafirlukast. Clinical experience and tolerability profile
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antileukotriene drugs in the management of asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Zileuton
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Montelukast
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A risk-benefit assessment of antileukotrienes in asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of single-dose zileuton on bronchial hyperresponsiveness in asthmatic patients treated with inhaled corticosteroids
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Worldwide clinical experience with the first marketed leukotriene receptor antagonist
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonist
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of pranlukast, a leukotriene receptor antagonist, in patients with severe asthma refractory to corticosteroids
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic effect of pranlukast, a selective cysteinyl leukotriene receptor antagonist, on bronchial asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of asthma with drugs modifying the leukotriene pathway.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Challenge studies of a leukotriene receptor antagonist
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Leukotriene antagonism in asthma and rhinitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reduced Allergen-Induced Nasal Congestion and Leukotriene Synthesis with an Orally Active 5-Lipoxygenase Inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Leukotriene-receptor antagonists
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized controlled trial comparing zileuton with theophylline in moderate asthma. The Zileuton Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Churg-Strauss syndrome associated with zafirlukast
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pulmonary eosinophilia associated with montelukast
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Formes frustes of Churg-Strauss syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Steroids and Churg-Strauss syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antileukotrienes in chronic urticaria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962309-5
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1081-1206(10)62309-5
1 reference
stated in
Europe PubMed Central
PubMed ID
11426914
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11426914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
PubMed ID
11426914
1 reference
stated in
Europe PubMed Central
PubMed ID
11426914
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11426914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit